-
Posted by
Two Blokes Jul 2 -
Filed in
General
-
#TwoBlokesTrading
-
6 views
China's biotech sector is rapidly advancing due to heavy R&D investment and a push for technological self-sufficiency, creating new opportunities for global investors. Chinese firms excel as 'fast followers,' licensing and commercializing Western drugs, while expanding their own innovation capabilities and global licensing deals.
